pancreatic cancer

42 projects

HEDoctoral network2027–2030Spain

radio3D · Next-Generation Radiopharmaceuticals for Glioblastoma and Pancreatic Cancer: A 3D Perspective

21 partners · 9 countries

HEStaff exchange2027–2030Greece

CTC4CLINIC · EXPLORING THE MECHANISM OF METASTASIS/DEVELOPMENT OF NEW TESTS TO ENROLL CIRCULATING TUMOR CELLS (CTCs) INTO CLINICAL PRACTICE

12 partners · 7 countries

HEIndividual fellowship2026–2028United Kingdom

PREDiCT-AI · AI-Driven Drug Discovery: Pancreatic Cancer Resistance via ENT1 Differential Conformation Tracking

2 partners · 2 countries

HEIndividual fellowship2026–2028Spain

DiscoverableTumor · Oncogene-driven immunosuppression via glyco-immune checkpoint modulation in pancreatic ductal adenocarcinoma.

HEIndividual fellowship2025–2027United Kingdom

CAFinCAC · Dissecting and targeting malignant cell-fibroblast crosstalk driving cachexia in pancreatic cancer

HEIndividual fellowship2024–2027Germany

PCPNIHyp · Exploring perineural invasion (PNI) mechanisms in Pancreatic Cancer using hyperpolarized 13C NMR

HEIndividual fellowship2024–2025Spain

NIR-NanoCAR · Near-Infrared Photothermal Nano-CAR Immunotherapy mediated by engineered exosomes targeted to pancreatic cancer with mutated KRAS

2 partners · 2 countries

H2020Individual fellowship2022–2024Spain

Onco-inflammation · Origin of genomic instability: Understanding the biological influence of inflammation in the initiation of pancreatic tumorigenesis

H2020Individual fellowship2021–2023Switzerland

NERVASION · Targeting microenvironment of cancer-invaded-nerves in pancreatic adenocarcinoma.

H2020Individual fellowship2021–2023Spain

PANC561 · LAM561 BEATS PANCREATIC CANCER

H2020Individual fellowship2020–2022Serbia

REPANCAN · Drug repurposing in pancreatic ductal adenocarcinoma

H2020Individual fellowship2020–2022Italy

OPEN P-CAN · Dissecting the role of mitochondrial dynamics in pancreatic carcinogenesis

H2020Individual fellowship2020–2022Spain

PDASwITch · Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer

H2020Individual fellowship2020–2022Spain

SPOT · Synthesis of Pretargeted Oncology Theranostics

H2020Doctoral network2019–2024Germany

PAVE · A nanovaccine Approach for the treatment of Pancreatic Cancer

15 partners · 7 countries

H2020Doctoral network2019–2024Germany

PRECODE · PancREatic Cancer OrganoiDs rEsearch Network

15 partners · 8 countries

H2020Individual fellowship2019–2021Germany

MultiPan · A Multi-omics Approach To Decode Epigenetic Lesions In Pancreatic Cancer Development

H2020Individual fellowship2019–2021Italy

MINT · Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer

H2020Individual fellowship2019–2021United Kingdom

PanILC · Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia

H2020Individual fellowship2019–2021United Kingdom

CentrosoTME · The role of extra centrosomes on the tumour microenvironment

H2020Individual fellowship2019–2021Spain

SHINE · Self-Healthcare for breast cancer detection using an INtegrated paper-based Electrochemical device

H2020Individual fellowship2019–2021Austria

ChemRAS · Chemical probing of transcriptional RAS effectors

H2020Doctoral network2018–2023Germany

pHioniC · pH and Ion Transport in Pancreatic Cancer

17 partners · 7 countries

H2020Individual fellowship2018–2020Poland

Proteasome in cancer · Identification of the proteasome machinery targets in human cancer